Cite

    Stark, C. et al. (2017). The real-world efficacy of botulinum toxin type a (botox®) for the prophylaxis of headaches in adult patients with chronic migraine in australian clinical practice: a retrospective chart review. Journal of neurology, neurosurgery and psychiatry. 88 (5), p. e1. [Online].